CPRX logo

Catalyst Pharmaceuticals, Inc. (CPRX) Gross Profit

Annual Gross Profit:

$385.51M+$71.84M(+22.90%)
December 31, 2024

Summary

  • As of today, CPRX annual gross profit is $385.51 million, with the most recent change of +$71.84 million (+22.90%) on December 31, 2024.
  • During the last 3 years, CPRX annual gross profit has risen by +$266.56 million (+224.10%).
  • CPRX annual gross profit is now at all-time high.

Performance

CPRX Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

Quarterly Gross Profit:

$116.61M+$2.44M(+2.14%)
June 30, 2025

Summary

  • As of today, CPRX quarterly gross profit is $116.61 million, with the most recent change of +$2.44 million (+2.14%) on June 30, 2025.
  • Over the past year, CPRX quarterly gross profit has increased by +$18.64 million (+19.03%).
  • CPRX quarterly gross profit is now at all-time high.

Performance

CPRX Quarterly Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

TTM Gross Profit:

$441.68M+$18.64M(+4.41%)
June 30, 2025

Summary

  • As of today, CPRX TTM gross profit is $441.68 million, with the most recent change of +$18.64 million (+4.41%) on June 30, 2025.
  • Over the past year, CPRX TTM gross profit has increased by +$101.34 million (+29.77%).
  • CPRX TTM gross profit is now at all-time high.

Performance

CPRX TTM Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

Gross Profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

CPRX Gross Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+22.9%+19.0%+29.8%
3Y3 Years+224.1%+156.4%+206.1%
5Y5 Years+340.4%+357.9%+334.7%

CPRX Gross Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+224.1%at high+145.1%at high+174.0%
5Y5-Yearat high+340.4%at high+358.4%at high+334.7%
All-TimeAll-Timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

CPRX Gross Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$116.61M(+2.1%)
$441.68M(+4.4%)
Mar 2025
-
$114.17M(+3.0%)
$423.03M(+9.7%)
Dec 2024
$385.51M(+22.9%)
$110.83M(+10.8%)
$385.51M(+7.0%)
Sep 2024
-
$100.07M(+2.2%)
$360.38M(+5.9%)
Jun 2024
-
$97.96M(+27.8%)
$340.34M(+5.9%)
Mar 2024
-
$76.64M(-10.6%)
$321.43M(+2.5%)
Dec 2023
$313.67M(+74.4%)
$85.70M(+7.1%)
$313.67M(+13.0%)
Sep 2023
-
$80.03M(+1.2%)
$277.53M(+13.2%)
Jun 2023
-
$79.05M(+14.7%)
$245.08M(+15.9%)
Mar 2023
-
$68.89M(+39.0%)
$211.50M(+17.6%)
Dec 2022
$179.81M(+51.2%)
$49.56M(+4.2%)
$179.81M(+11.5%)
Sep 2022
-
$47.58M(+4.6%)
$161.21M(+11.7%)
Jun 2022
-
$45.47M(+22.2%)
$144.27M(+10.4%)
Mar 2022
-
$37.20M(+20.1%)
$130.62M(+9.8%)
Dec 2021
$118.95M(+16.6%)
$30.96M(+1.0%)
$118.95M(+4.2%)
Sep 2021
-
$30.64M(-3.7%)
$114.13M(+4.8%)
Jun 2021
-
$31.82M(+24.7%)
$108.93M(+6.2%)
Mar 2021
-
$25.52M(-2.4%)
$102.57M(+0.5%)
Dec 2020
$102.03M(+16.5%)
$26.15M(+2.8%)
$102.03M(+0.4%)
Sep 2020
-
$25.44M(-0.1%)
$101.61M(-1.0%)
Jun 2020
-
$25.46M(+1.9%)
$102.68M(+0.9%)
Mar 2020
-
$24.99M(-2.9%)
$101.79M(+16.3%)
Dec 2019
$87.55M(>+9900.0%)
$25.72M(-3.0%)
$87.53M(+40.5%)
Sep 2019
-
$26.51M(+7.9%)
$62.29M(+74.1%)
Jun 2019
-
$24.57M(+129.1%)
$35.77M(+219.6%)
Mar 2019
-
$10.72M(+2099.6%)
$11.19M(+2322.7%)
Dec 2018
$0.00(+100.0%)
$487.50K(+5341.9%)
$462.00K(+1525.9%)
Sep 2018
-
-$9300.00(-13.4%)
-$32.40K(+9.7%)
Jun 2018
-
-$8200.00(-2.5%)
-$35.90K(+11.8%)
Mar 2018
-
-$8000.00(-15.9%)
-$40.70K(+10.9%)
Dec 2017
-$45.70K(-5.3%)
-$6900.00(+46.1%)
-$45.70K(+10.0%)
Sep 2017
-
-$12.80K(+1.5%)
-$50.80K(-6.9%)
Jun 2017
-
-$13.00K(0.0%)
-$47.50K(-9.7%)
Mar 2017
-
-$13.00K(-8.3%)
-$43.30K(+0.5%)
Dec 2016
-$43.40K(-25.8%)
-$12.00K(-26.3%)
-$43.50K(-15.7%)
Sep 2016
-
-$9500.00(-8.0%)
-$37.60K(+4.6%)
Jun 2016
-
-$8800.00(+33.3%)
-$39.40K(+0.5%)
Mar 2016
-
-$13.20K(-116.4%)
-$39.60K(-14.8%)
Dec 2015
-$34.50K
-$6100.00(+46.0%)
-$34.50K(+5.2%)
Sep 2015
-
-$11.30K(-25.6%)
-$36.40K(-12.7%)
Jun 2015
-
-$9000.00(-11.1%)
-$32.30K(-9.9%)
DateAnnualQuarterlyTTM
Mar 2015
-
-$8100.00(-1.3%)
-$29.40K(-10.5%)
Dec 2014
-$26.60K(-18.2%)
-$8000.00(-11.1%)
-$26.60K(-9.5%)
Sep 2014
-
-$7200.00(-18.0%)
-$24.30K(-6.6%)
Jun 2014
-
-$6100.00(-15.1%)
-$22.80K(-1.8%)
Mar 2014
-
-$5300.00(+7.0%)
-$22.40K(-31.0%)
Dec 2013
-$22.50K(-106.4%)
-$5700.00(0.0%)
-$17.10K(-21.3%)
Sep 2013
-
-$5700.00(0.0%)
-$14.10K(-27.0%)
Jun 2013
-
-$5700.00(>-9900.0%)
-$11.10K(-37.0%)
Mar 2013
-
$0.00(+100.0%)
-$8100.00(+98.9%)
Dec 2012
-$10.90K(+74.5%)
-$2700.00(0.0%)
-$735.40K(+0.7%)
Sep 2012
-
-$2700.00(0.0%)
-$740.60K(+0.6%)
Jun 2012
-
-$2700.00(+99.6%)
-$745.40K(+2.4%)
Mar 2012
-
-$727.30K(-9106.3%)
-$763.70K(-1684.3%)
Dec 2011
-$42.80K(>-9900.0%)
-$7900.00(-5.3%)
-$42.80K(-3.6%)
Sep 2011
-
-$7500.00(+64.3%)
-$41.30K(-22.2%)
Jun 2011
-
-$21.00K(-228.1%)
-$33.80K(-164.1%)
Mar 2011
-
-$6400.00(0.0%)
-$12.80K(-100.0%)
Dec 2010
$0.00(0.0%)
-$6400.00(>-9900.0%)
-$6400.00(>-9900.0%)
Sep 2010
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2010
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2010
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2009
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2009
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2009
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2008
$0.00(0.0%)
$0.00(0.0%)
$0.00(+100.0%)
Sep 2008
-
$0.00(0.0%)
-$7700.00(0.0%)
Jun 2008
-
$0.00(0.0%)
-$7700.00(0.0%)
Mar 2008
-
$0.00(+100.0%)
-$7700.00(0.0%)
Dec 2007
$0.00(0.0%)
-$7700.00(>-9900.0%)
-$7700.00(>-9900.0%)
Sep 2007
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2007
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2007
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2006
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2006
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2006
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2006
-
$0.00
$0.00
Dec 2005
$0.00(0.0%)
-
-
Dec 2004
$0.00(0.0%)
-
-
Dec 2003
$0.00(0.0%)
-
-
Dec 2002
$0.00
-
-

FAQ

  • What is Catalyst Pharmaceuticals, Inc. annual gross profit?
  • What is the all-time high annual gross profit for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. annual gross profit year-on-year change?
  • What is Catalyst Pharmaceuticals, Inc. quarterly gross profit?
  • What is the all-time high quarterly gross profit for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. quarterly gross profit year-on-year change?
  • What is Catalyst Pharmaceuticals, Inc. TTM gross profit?
  • What is the all-time high TTM gross profit for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. TTM gross profit year-on-year change?

What is Catalyst Pharmaceuticals, Inc. annual gross profit?

The current annual gross profit of CPRX is $385.51M

What is the all-time high annual gross profit for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high annual gross profit is $385.51M

What is Catalyst Pharmaceuticals, Inc. annual gross profit year-on-year change?

Over the past year, CPRX annual gross profit has changed by +$71.84M (+22.90%)

What is Catalyst Pharmaceuticals, Inc. quarterly gross profit?

The current quarterly gross profit of CPRX is $116.61M

What is the all-time high quarterly gross profit for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high quarterly gross profit is $116.61M

What is Catalyst Pharmaceuticals, Inc. quarterly gross profit year-on-year change?

Over the past year, CPRX quarterly gross profit has changed by +$18.64M (+19.03%)

What is Catalyst Pharmaceuticals, Inc. TTM gross profit?

The current TTM gross profit of CPRX is $441.68M

What is the all-time high TTM gross profit for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high TTM gross profit is $441.68M

What is Catalyst Pharmaceuticals, Inc. TTM gross profit year-on-year change?

Over the past year, CPRX TTM gross profit has changed by +$101.34M (+29.77%)
On this page